ATE139440T1 - Behandlung von entzündlichen darmerkrankungen - Google Patents

Behandlung von entzündlichen darmerkrankungen

Info

Publication number: ATE139440T1
Authority: AT; Austria
Prior art keywords: inflammatory bowel; bowel disease; treatment; disease; carboxypyrazoles
Prior art date: 1992-07-07

Application number

AT93305298T

Other languages

English (en)

Inventor

David Russell Blake

Peter Pack-Koh Ho

Jill Ann Panetta

David Stephen Rampton

Nicola Jane Simmonds

Original Assignee

Lilly Co Eli

London Hospital Med Coll

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-07

Filing date

1993-07-06

Publication date

1996-07-15

1993-07-06 Application filed by Lilly Co Eli, London Hospital Med Coll filed Critical Lilly Co Eli

1996-07-15 Application granted granted Critical

1996-07-15 Publication of ATE139440T1 publication Critical patent/ATE139440T1/de

Links

208000022559 Inflammatory bowel disease Diseases 0.000 title abstract 2
QBPUOAJBMXXBNU-UHFFFAOYSA-N 3-phenyl-1H-pyrazole-5-carboxylic acid Chemical class N1C(C(=O)O)=CC(C=2C=CC=CC=2)=N1 QBPUOAJBMXXBNU-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
150000003854 isothiazoles Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AT93305298T 1992-07-07 1993-07-06 Behandlung von entzündlichen darmerkrankungen ATE139440T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/909,852 US5294630A (en)	1992-07-07	1992-07-07	Treatment of inflammatory bowel disease

Publications (1)

Publication Number	Publication Date
ATE139440T1 true ATE139440T1 (de)	1996-07-15

Family

ID=25427924

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93305298T ATE139440T1 (de)	1992-07-07	1993-07-06	Behandlung von entzündlichen darmerkrankungen

Country Status (11)

Country	Link
US (1)	US5294630A (de)
EP (1)	EP0578477B1 (de)
JP (1)	JPH06157310A (de)
AT (1)	ATE139440T1 (de)
AU (1)	AU672977B2 (de)
CA (1)	CA2099789A1 (de)
DE (1)	DE69303234T2 (de)
DK (1)	DK0578477T3 (de)
ES (1)	ES2090875T3 (de)
GR (1)	GR3021114T3 (de)
ZA (1)	ZA934740B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH10168095A (ja)	1996-12-10	1998-06-23	Cci Corp	炎症性腸疾患予防および治療剤
US6485938B1 (en) *	1999-11-16	2002-11-26	Zymogenetics, Inc.	Nucleic acid molecules that encodes human Zven1
US6989377B2 (en)	1999-12-21	2006-01-24	Wisconsin Alumni Research Foundation	Treating vitamin D responsive diseases
US6358939B1 (en)	1999-12-21	2002-03-19	Northern Lights Pharmaceuticals, Llc	Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US20030118329A1 (en) *	2001-12-21	2003-06-26	Pere Obrador	Video indexing using high resolution still images
US7205110B2 (en) *	2002-10-07	2007-04-17	Zymogenetics, Inc.	Uses of human Zven antagonists
WO2005072113A2 (en)	2004-01-20	2005-08-11	Harty Richard F	Compositions and methods of treatment for inflammatory diseases
CA2622575A1 (en) *	2005-09-13	2007-03-22	Zymogenetics, Inc.	Prok2 antagonists and methods of use
ES2276618B1 (es) *	2005-12-02	2008-06-16	Laboratorios Casen-Fleet, S.L.	Utilizacion rectal de una solucion de cloruro de sodio.
WO2008069102A1 (ja) *	2006-12-06	2008-06-12	Calpis Co., Ltd.	炎症性腸疾患予防治療剤
WO2010042933A2 (en)	2008-10-10	2010-04-15	Northwestern University	Inhibition and treatment of prostate cancer metastasis
JP2017534627A (ja)	2014-11-06	2017-11-24	ノースウエスタンユニバーシティＮｏｒｔｈｗｅｓｔｅｒｎＵｎｉｖｅｒｓｉｔｙ	癌細胞運動性の阻害

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4346094A (en) *	1980-09-22	1982-08-24	Eli Lilly And Company	3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels
US4544752A (en) *	1980-09-22	1985-10-01	Eli Lilly And Company	3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels
US4495195A (en) *	1982-11-01	1985-01-22	Eli Lilly And Company	Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use
DK0513379T3 (da) *	1990-11-30	1996-09-30	Teijin Ltd	2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne

1992
- 1992-07-07 US US07/909,852 patent/US5294630A/en not_active Expired - Fee Related
1993
- 1993-07-01 ZA ZA934740A patent/ZA934740B/xx unknown
- 1993-07-05 AU AU41758/93A patent/AU672977B2/en not_active Ceased
- 1993-07-05 CA CA002099789A patent/CA2099789A1/en not_active Abandoned
- 1993-07-06 EP EP93305298A patent/EP0578477B1/de not_active Expired - Lifetime
- 1993-07-06 ES ES93305298T patent/ES2090875T3/es not_active Expired - Lifetime
- 1993-07-06 JP JP5166779A patent/JPH06157310A/ja active Pending
- 1993-07-06 AT AT93305298T patent/ATE139440T1/de not_active IP Right Cessation
- 1993-07-06 DE DE69303234T patent/DE69303234T2/de not_active Expired - Fee Related
- 1993-07-06 DK DK93305298.7T patent/DK0578477T3/da active
1996
- 1996-09-19 GR GR960402479T patent/GR3021114T3/el unknown

Also Published As

Publication number	Publication date
EP0578477A1 (de)	1994-01-12
ZA934740B (en)	1995-01-03
CA2099789A1 (en)	1994-01-08
AU4175893A (en)	1994-01-13
ES2090875T3 (es)	1996-10-16
EP0578477B1 (de)	1996-06-19
AU672977B2 (en)	1996-10-24
DE69303234D1 (de)	1996-07-25
US5294630A (en)	1994-03-15
GR3021114T3 (en)	1996-12-31
DE69303234T2 (de)	1996-11-21
DK0578477T3 (da)	1996-07-15
JPH06157310A (ja)	1994-06-03

Legal Events

Date	Code	Title
1997-01-15	EEFA	Change of the company name
1997-02-15	UEP	Publication of translation of european patent specification
2004-04-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE143263T1 (de)	1996-10-15	Behandlung von neurodegenerativen erkrankungen
DE69129800D1 (de)	1998-08-20	Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
ATE82121T1 (de)	1992-11-15	Arzneimittel fuer die therapeutische behandlung von alopezie.
DE69110561D1 (de)	1995-07-27	Mittel zur Behandlung und Vorbeugung von Bauchentzündungen, die als Wirkstoff Zink-L-Carnosin-Salze oder -Komplexe enthalten.
DE69402173D1 (de)	1997-04-24	Hemmung von Thrombin
DE68909219D1 (de)	1993-10-21	Behandlung von obesitas.
DE69523350D1 (de)	2001-11-29	Behandlung von hyperproliferativen Gefässerkrankungen
NO951432L (no)	1995-05-12	Farmasöytiske preparater
ATE224714T1 (de)	2002-10-15	Behandlung von tinnitus mit neuroprotektiven wirkstoffen
DE3780091D1 (de)	1992-08-06	Behandlung von pilzinfektionen.
DE68907423D1 (de)	1993-08-12	Behandlung der akne.
ATE139440T1 (de)	1996-07-15	Behandlung von entzündlichen darmerkrankungen
DE3777861D1 (de)	1992-05-07	Behandlung von gasen.
ATE128459T1 (de)	1995-10-15	Sulfonanilidderivat und arzneimittel.
DE68903092D1 (de)	1992-11-05	Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DE69300321D1 (de)	1995-09-07	Behandlung neurodegenerativer Erkrankungen.
DE68923219D1 (de)	1995-08-03	Behandlung von Abfällen.
DE68909465D1 (de)	1993-11-04	Behandlung von pferdeviehbestand.
ATE91415T1 (de)	1993-07-15	Phenoxy- und phenylthio-, amino-substituierte benzocyclo-alkan-derivate bei der behandlung und verhuetung von arzneimittelresistenten protozoen- infektionen.
ATE75399T1 (de)	1992-05-15	Therapeutikum zur behandlung von magengeschwueren.
ATE88634T1 (de)	1993-05-15	Arzneimittel zur behandlung von herzinsuffizienz.
DE69108357D1 (de)	1995-04-27	Behandlung von verdünnten säurehaltigen Lösungen.
DE3674321D1 (de)	1990-10-25	Behandlung geschmeidiger gewebe.
DE68919369D1 (de)	1994-12-15	Orthodontische behandlung.
DE69619088D1 (de)	2002-03-21	Quinoxalin-Derivate zur Behandlung von Tinnitus